Search results
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
US News & World Report· 5 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the ...
Gateway - The Root
The Root· 17 minutes agoHealth experts in Mississippi and the federal level are urging residents in the state not to ingest ivermectin to treat COVID-19. In case you wanna know what ivermectin is ...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 5 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
Gateway - Quartz
Quartz· 13 hours agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines ...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 7 days agoThis combination caused a mechanical reaction of profit squeeze, which is unlikely to be sustained as inflation stabilizes and Pfizer's revenue sources...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
New COVID Mystery? Those 'Excess Deaths'
newser· 2 days agoWith hospitals swamped at the same time, excess deaths spiked considerably from causes including heart disease, stroke, and diabetes. COVID vaccines...
Gateway - Quartz
Quartz· 4 hours agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country even as relations ...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 18 hours agoCoreFirst Bank & Trust decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 2 days agoNovavax’s filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine manufacturers Moderna (MRNA Quick QuoteMRNA - Free Report ...
